WS Audiology key facts
as of Oct 2026- Developer and manufacturer of leading-edge hearing aids designed for better hearing and understanding.
- WS Audiology is valued at approximately $2.6B as of Oct 2026 (last reported valuation).
- It has raised $10.0B; the latest was Debt Refinancing in Jan 2026.
- Notable investors include T&W Medical, Lundbeckfonden, Ardian France, Athos (Family Office), EQT — 6 tracked in total.
- Status: Privately Held (backing).
WS Audiology's last reported valuation, Jan 2015. Nothing priced has surfaced since.
- ·Watch WS Audiology: the Monday email on marks, rounds and moves
WS Audiology funding rounds
No funding rounds for WS Audiology are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Who backs WS Audiology
6WS Audiology valuation
WS Audiology's last reported valuation was $2.6 billion in Jan 2015. No priced round, secondary trade or fund mark has surfaced since.
WS Audiology investors
6 investors are on record for WS Audiology, including T&W Medical, Lundbeckfonden, Ardian France and Athos (Family Office).
About WS Audiology
Developer and manufacturer of leading-edge hearing aids designed for better hearing and understanding. The company's product spectrum covers the full range of hearing aids and accessories across all price categories and is sold via several brands, enabling patients suffering from hearing loss to live an improved life.
- Sector
- Healthcare
- HQ
- Lynge, Denmark
- Founded
- 1877
- Employees
- 12,000
- Website
- wsa.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.